Migdal Insurance & Financial Holdings Ltd.

Institutional investor · Portfolio as of Q2 2025

Q2 2025 biggest moves
  • METAMETA

    Meta Platforms

    68× the shares

    now 1.9% of portfolio

  • NVDANVDA

    NVIDIA

    2.3× the shares

    now 1.8% of portfolio

  • LLYLLY

    Eli Lilly and

    Added 82%

    now 1.5% of portfolio

  • GOOGGOOG

    Alphabet

    Cut 28%

    now 1.9% of portfolio

373 changes in all

Top Holdings357 positions

Checking export access…
Activity:
XLK
XLK
ETF

SELECT SECTOR SPDR TR

2.6M$659.3M7.8%$104.20+20.73%
16 qtrssince 2021-Q3
Increased
89
XLI
XLI
ETF

SELECT SECTOR SPDR TR

3.6M$532.4M6.3%$113.55+27.92%
23 qtrssince 2019-Q4
Increased
72
TEVA
TEVA
ADR

Teva Pharmaceutical Industries Limited

28.7M$480.8M5.7%$10.52+59.29%
23 qtrssince 2019-Q4
Increased
66
KBWB
KBWB
ETF

INVESCO EXCH TRADED FD TR II

5.6M$400.7M4.8%$65.23+6.83%
8 qtrssince 2023-Q3
Increased
84
NVMI

Nova Ltd.

1.4M$395.6M4.7%$105.98+159.68%
23 qtrssince 2019-Q4
Increased
65
AMZN

Amazon.com, Inc.

1.4M$311.1M3.7%$145.63+50.64%
23 qtrssince 2019-Q4
Increased
62
NICE
NICE
ADR

NICE Ltd

1.8M$309.4M3.7%$172.43-2.04%
23 qtrssince 2019-Q4
Increased
59
IGV
IGV
ETF

ISHARES TR

2.7M$297.8M3.5%——
23 qtrssince 2019-Q4
Increased
62
XLC
XLC
ETF

SELECT SECTOR SPDR TR

2.6M$281.3M3.3%$69.22+54.34%
23 qtrssince 2019-Q4
Increased
61
TSM
TSM
ADR

Taiwan Semiconductor Manufacturing Company Ltd.

1.2M$274.9M3.3%$152.24+46.75%
23 qtrssince 2019-Q4
Decreased
0
XLY
XLY
ETF

SELECT SECTOR SPDR TR

1.2M$252.2M3.0%$97.53+10.31%
23 qtrssince 2019-Q4
Increased
65
LQD
LQD
ETF

ISHARES TR

2M$215.4M2.6%$101.24+1.43%
23 qtrssince 2019-Q4
Unchanged
0
XLU
XLU
ETF

SELECT SECTOR SPDR TR

2.5M$204.1M2.4%$38.08+3.54%
5 qtrssince 2024-Q2
Increased
54
AAPL

Apple Inc.

980,700$201.2M2.4%$190.81+6.93%
23 qtrssince 2019-Q4
Increased
53
XLF
XLF
ETF

SELECT SECTOR SPDR TR

3.1M$163.8M1.9%$43.61+17.84%
23 qtrssince 2019-Q4
Decreased
0
GOOG

Alphabet Inc.

895,855$158.9M1.9%$152.14+16.19%
23 qtrssince 2019-Q4
Decreased
0
META

Meta Platforms, Inc.

213,387$157.5M1.9%$728.33+0.93%
23 qtrssince 2019-Q4
Increased
77
NVDA

NVIDIA Corporation

969,279$153.1M1.8%$116.68+35.07%
23 qtrssince 2019-Q4
Increased
77
LLY

Eli Lilly and Company

164,725$128.4M1.5%$800.71-3.58%
8 qtrssince 2023-Q3
Increased
73
SMH
SMH
ETF

VANECK ETF TRUST

453,000$126.3M1.5%$278.010.00%
6 qtrssince 2024-Q1
Increased
77
$8.4B
AUM
357
Positions
Q2 2025
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2024-Q1$6,249,16325.8593163574%
2024-Q2$5,989,118,00095738.7227217%
2024-Q3$6,183,901,0003.25228188859%
2024-Q4$6,971,125,00012.7302167354%
2025-Q1$7,120,742,0002.14623894995%
2025-Q2$8,423,820,00018.2997502227%
Activity profile
$ moved · Q2'25
New4%Increased60%Decreased30%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.3 years
<1Q6%1-4Q8%1-2Y15%2Y+71%

Migdal Insurance & Financial Holdings Ltd. manages $8.4B across 357 positions as of Q2 2025. Top holdings: XLK (7.8%), XLI (6.3%), TEVA (5.7%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$8B
XLK7.83%
XLI6.32%
TEVA5.71%
KBWB4.76%
NVMI4.70%
AMZN3.69%
NICE3.67%
IGV3.54%
XLC3.34%
TSM3.26%
Other2.99%

Portfolio allocation by GICS sector

Sectors11
Unknown49.19%
Technology26.49%
Healthcare7.68%
Consumer Cyclical6.39%
Communication Services4.56%
Financial Services3.30%
Utilities1.30%
Real Estate0.63%
Consumer Defensive0.23%
Industrials0.23%
Other0.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L42
Conviction51
Concentration69
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CEMBCEMBISHARES INC
Q4 2024 → Q3 2026+16,425 shares+$711,700
8Q
TEVATEVATeva Pharmaceutical Industries Limited
Q4 2024 → Q3 2026+14M shares+$1.1B
8Q
VCSHVCSHVANGUARD SCOTTSDALE FDS
Q4 2024 → Q3 2026+83,708 shares+$6.4M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used